Atrial Fibrillation Market Is Projected To Reach $13.2% from 2014 to 2020: Grand View Research, Inc.

The global atrial fibrillation market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand.

Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.

Browse full research report on Atrial Fibrillation Market: https://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry

North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth.

Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth.

Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years.

Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period.

Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the global atrial fibrillation market on the basis of fields of procedures and region:

Atrial Fibrillation Procedures Outlook

  • Pharmacological Products
  • Anti-arrhythmic Drugs
  • Anti-coagulant Drugs
  • Non-Pharmacological Treatment
  • Catheter Ablation Procedures
  • Radiofrequency
  • HIFU
  • Cryoablation
  • Microwave
  • Laser
  • Maze Surgery
  • Electric Cardioversion

Atrial Fibrillation Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access Press Release By Grand View Research: https://www.grandviewresearch.com/press-release/global-atrial-fibrillation-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Advertisements

Peripheral Vascular Devices Market Is Projected To Grow Rapidly Due To Rising Global Prevalence Of Venous Diseases Or CVI Till 2020: Grand View Research, Inc.

The global peripheral vascular devices market is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries. These devices are used to decrease the interference of patients with minimum disturbance during the surgical procedure.

Increasing global geriatric population base triggering incidence rates of target diseases, extensive presence of both private and public external funding programs, changing lifestyle and eating habits are expected to be key driving factors for this market over the next six years. In addition, presence of untapped growth opportunities in emerging markets such as India, Brazil and China and increasing health awareness are also expected to serve this market as future growth opportunities.

Peripheral Vascular Devices Market, by Product, 2013

 

peripheral-vascular-devices-market

Browse full research report on Peripheral Vascular Devices Market: http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market           

Further key findings from the report suggest:

  • Peripheral vascular stents dominated the peripheral vascular devices market in terms of share at over 30.8% in 2013; driven by increasing demand for drug eluting and bio-absorbable stents. Moreover, the ability of these devices to significantly reduce re-stenosis rates is expected to boost product demand.
  • Embolic protection devices market is expected to grow at the fastest CAGR of 9.2% during the forecast period; owing to increasing demand for minimally invasive endovascular surgical method for removing atherosclerosis from large blood vessels.
  • North America was the largest regional market in 2013, accounting for 40.3% of the global revenue. Presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and high R&D pertaining to drug discovery and development are some of the factors accounting for its large share.
  • Asia Pacific peripheral vascular devices market is expected to grow at the fastest CAGR of 10.0% from 2014 to 2020; primarily owing to the wide presence of unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China.
  • Key industry participants of this market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, W.L.Gore and Associates Ltd. and Angioscore Ltd.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare       

Grand View Research has segmented the peripheral vascular devices market on the basis of product and region:

Peripheral Vascular Devices Product Outlook

  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty Balloon Catheters
  • PTA Guidewires
  • Atherectomy Devices
  • Chronic Total Occlusion Devices
  • Aortic Stents
  • Synthetic Surgical Grafts
  • Embolic Protection Devices
  • Inferior Vena Cava Filters

Peripheral Vascular Devices Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-peripheral-vascular-devices-market      

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Women’s Health Market Is Predicted To Grow Swiftly Due To Increasing Female Geriatric Population Till 2025: Grand View Research, Inc.

The global women’s health market is expected to reach USD 51.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing female geriatric population, introduction of various drugs related to women’s health, and favorable government policies are some of the factors expected to drive growth during the forecast period.

Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years. According to International Osteoporosis Foundation, global prevalence of osteoporosis among women was over 200.0 million in 1990, and this is anticipated to reach 680.0 million in 2050.

Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.

U.S. women’s health market by application, 2014 – 2025 (USD Billion)

us-womens-health-market.png

Browse full research report on Women’s Health Market: http://www.grandviewresearch.com/industry-analysis/womens-health-market

Further Key Findings From the Study Suggest:

  • Presence of a large female geriatric population, which is susceptible to chronic diseases, is expected to boost growth
  • In 2016, postmenopausal osteoporosis accounted for the largest share of the market due to high incidence of osteoporosis in women after menopause, presence of several major players, and cost-effectiveness of this treatment
  • Contraceptive segment is likely to witness fastest growth during the forecast period due to increase in awareness and usage, government initiatives, technological developments, and favorable regulatory scenario. For instance, in June 2017, Agile Therapeutics, Inc. resubmitted an NDA for Twirla, an investigational low-dose combined hormonal contraceptive patch
  • Geographically, North America held the largest share of more than 30% in 2016 due to presence of major market players, high awareness about regular health check-ups for women, coverage for screening, and increased healthcare expenditure
  • Asia Pacific is expected to exhibit fastest growth during the forecast period due to increasing investments by players in the region, rising awareness about women’s health, and initiatives by various governments and private organizations to improve awareness and access to women’s health products
  • Some of the key players operating in the women’s health market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb Company; and Ferring B.V.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-womens-health-market                                                                                                

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Hematologic Malignancies Market Is Predicted To Grow Swiftly Due To The Increasing Investment In Cancer Research Till 2025: Grand View Research, Inc.

The global hematologic malignancies market is estimated to reach USD 85.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of hematologic malignancies and presence of a strong product pipeline are estimated to boost the market. Moreover, increasing number of mergers and acquisitions are also expected to accelerate growth.

Furthermore, governments of developing countries are spending more on healthcare and on improving healthcare infrastructure. This is likely to reduce out-of-pocket expenditure for patients. which is considered as one of the major factors driving the hematologic malignancies market.

Recently it has been seen that the government sources are taking an initiative in funding the institutes for breakthrough oncology research. This is a major growth driver for the market as it will support the institutes to conduct their research on a larger-scale without any financial constraints. Federal government funding for research in oncology has led to a substantial development in cancer detection, prevention, diagnosis, treatment and quality of life for patients. Due to the advancement in cancer research, more patients with cancer are being successfully treated. The increasing investment in cancer research is expected to boost the growth of market during forecast period

U.S. hematologic malignancies market by type, 2014 – 2025 (USD Billion)

 

hemo2.jpg

Browse full research report on Hematologic Malignancies Market: http://www.grandviewresearch.com/industry-analysis/hematologic-malignancies-market

Further Key Findings From the Study Suggest:

  • Multiple myeloma is expected to be one of the fastest growing segments over the forecast period owing to strong pipeline of blockbuster products
  • Chronic myeloid leukemia was identified as the largest leukemia subtype in 2016 due to availability of large number of products and high number of target population
  • Chemotherapy held the largest share in 2016 on the basis of therapy due to its preference as first line of therapy and wide product range
  • Immunotherapy is anticipated to be the fastest growing segment and this can be attributed to lower adverse effects and higher efficiency
  • North America dominated the market in 2016 owing to local presence of key players and increasing number of mergers and acquisitions
  • Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to improving economic conditions and rising healthcare expenditure
  • Some of the key players are Pfizer, Inc.; F. Hoffmann-LA Roche Ltd; Sanofi; Bristol-Myers Squibb Company; AbbVie, Inc.; Novartis AG; GlaxoSmithKline PLC; Celgene Corporation; Johnson & Johnson Services, Inc.; and Takeda Pharmaceutical Company Limited
  • Most of the key players are focusing on expanding their product portfolios, development of new treatment, and acquisitions.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-hematologic-malignancies-market                                                                                             

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

VRL Market Worth USD 5.13 Billion By 2025: Grand View Research, Inc.

The global veterinary reference laboratories (VRL) market is expected to reach USD 5.13 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of zoonotic diseases is a key driving factor for market growth. Increase in adoption of integrated diagnostic systems coupled with information ecosystems for veterinary diagnostics is anticipated to fuel development.

Rise in demand for advanced diagnostic tests and growing awareness amongst consumers are some of the factors expected to boostdemandover the coming years. Moreover, companies are investing in R&D for the advancement of test kits for cost-effective diagnosis & monitoring of animal health, which is expected to boost growth. Some of the advancements in this market include efficient information management systems used in animal diagnostic applications, vaccine banks, and mobile apps for continuous monitoring. High focus toward innovation in veterinary health is anticipated to fuel the demand for reference labs. For instance, Innovative Medicines Initiative (IMI) is a public-private partnership that supports pharmaceutical innovations in Europe.

In addition, MediLabSecure, a laboratory network project was established, which aims to identify emerging viruses& pathogens in 19 countries in the Mediterranean regions and 57 labs were involved. Furthermore, increase in the number of government initiatives to promote veterinary diagnostics products is presumed to drive the overall growth.

U.S. VRL market revenue by animal type, 2014 – 2025 (USD million)

us-vrl-market.png

Browse full research report on Veterinary Reference Laboratory (VRL) Market: http://www.grandviewresearch.com/industry-analysis/veterinary-reference-laboratory-vrl-market

Further key findings from the report suggest:

  • The clinical chemistry analyzers segment held the dominant share of the market as of 2016 owing to growing demand for veterinary diagnostics products
  • Increase ininstances of contamination in pet foods that causesevere illnesses and deaths amongst animalsis expected to boost the demand for toxicology testing services
  • Production animals accounted for largest revenue share in 2016 owing to their highest consumption rate
  • The market was dominated by North America and is expected to retain its position throughout the forecast period
  • Presence of prominent industry players, advanced healthcare infrastructure, and high healthcare expenditure are some of the factors responsible for growth
  • Companies offering reference laboratories are focusing on the development of cost-effective diagnostic solutions for animal health
  • IDEXX Laboratories, Inc. held a dominant share owing to its presence across the globe and a wide product portfolio of advanced diagnostic tests
  • Strategies such as regional expansion, new product developments, merger & acquisitions, and research collaborations are anticipated to propel growth
  • For instance, inJanuary 2017, Mars, Inc. announced the agreement for acquiring VCA Inc. in a probe to capture higher share

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-veterinary-reference-laboratory-vrl-market                                                                      

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Protein Purification & Isolation Market Is Projected To Grow Rapidly Due To Increasing R&D Investments By Pharmaceutical Companies Till 2025: Grand View Research, Inc.

The global protein purification and isolation market is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.

Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques.

U.S. protein purification & isolation market, by technology, 2014 – 2025 (USD Billion)

us-protein-purification-isolation-market.png

Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysis/protein-purification-isolation-market

Further key findings from the report suggest:

  • Reagents were observed to be the largest as well as the fastest growing segment under the product outlook. These are highly used during cell lysis and help in separating soluble proteins from the cell debris.
  • Increasing adoption of automated protein purification techniques for achieving desired purity & process consistency and saving time is estimated to result in stable growth of the segment
  • On the basis of technology, chromatography held a significant share of the market owing to factors such as high reliability, availability of a wide range of products, and improved results for purifying complex proteins.
  • High R&D initiatives undertaken by market players for the screening of potential drugs through protein-protein interaction and structure-based studies is estimated to contribute toward fastest growth of the drug screening segment
  • By end use, CROs are considered as the fastest growing segment. Increase in investments in the R&D sector is expected to contribute toward market growth
  • In 2016, North America held the largest share owing to advancements in the technology, presence of major players, and established infrastructure especially in this region, which acts as a driving force to the market
  • The highest CAGR is anticipated in Asia Pacific over the forecast period due to a rise in economic stability, increasing number of CROs, and growing R&D in academic & research institutes
  • Some of the key players of this market are Thermo Fisher Scientific; Merck KGaA; Sigma-Aldrich Co.; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies; Promega Corporation; GE Healthcare; Norgen Biotek Corporation; and Abcam plc.
  • Some of the strategies implemented by these companies are mergers & acquisitions, strategic collaborations, and expansion of product portfolio through R&D initiatives, which have helped the market grow.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-protein-purification-isolation-market                                                                   

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Healthcare EDI Market Is Projected To Reach $5.9 Billion By 2025: Grand View Research, Inc.

The global healthcare EDI market is anticipated to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 9.4% over the forecast period, owing to increasing government support for healthcare IT coupled with surge in number of end-users and increasing adoption of EDI.

In 2010, the ObamaCare Act (the Affordable Care Act) was passed in the U.S., which mandated the use of enrolled/dis-enrolled transactions between the payers and providers in the U.S. Implementation of favorable policy such as Health Insurance Portability & Accountability Act (HIPAA) to provide data privacy and security provisions to protect medical information is anticipated to propel the market growth. Increasing government funding for the EDI-Special Project congressional grants is befitting hospitals and non-profit organization, thereby expected to foster the market growth.

A surge in number of end-users such as payers, providers, pharmaceutical & medical device industries, and others are anticipated to fuel the demand of the EDI services or solutions during the market period. The healthcare payers use EDI for the evaluation of insurance claims before their payment settlement, prevention & detection of fraudulent claims to provide rapid services through collaborating with providers in order to gain a competitive advantage.

U.S. healthcare EDI market, by delivery mode, 2014 – 2025 (USD Million)

us-healthcare-edi-market.png

Browse full research report on Healthcare EDI Market: http://www.grandviewresearch.com/industry-analysis/healthcare-electronic-data-interchange-edi-market

Further key findings from the report suggest:

  • The services segment held lucrative market share in 2016 and is expected to grow at a significant rate over the forecast period, owing to growing demand from healthcare and insurance providers for healthcare claims filing, its verification, and accounts receivables
  • The mobile EDI segment is expected to be the fastest growing segment over the forecast period due to technological developments in the healthcare industry and rising adoption of mobile solutions from healthcare providers
  • North America is expected to dominate the healthcare EDI market over the forecast period due to rising demand for innovative IT solutions to streamline workflows coupled with increasing regulatory requirements regarding patient safety
  • Some of the key players in healthcare EDI market are GE Healthcare; McKesson Corporation; Cognizant; Allscripts Healthcare Solutions Inc.; Siemens Healthineers; Optum, Inc.; Schreiner Group; The SSI Group, LLC; ZirMed Inc.; and Experian Information Solutions, Inc.

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-healthcare-electronic-data-interchange-edi-market                                       

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com